RxDoctor Payments Data

Maria Pantano, DO

Family Medicine · Wood Ridge, NJNPI 1841405008

Payments from drug & device makers

$9,665in general payments, 2019–2025

Across 691 payments — averaging $13.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$3K
  • AbbVie$667
  • Abbott$637
  • Kowa Pharmaceuticals America, Inc.$514
  • Boehringer Ingelheim$508
  • Amarin Pharma, Inc.$439
  • plus $4K from 40 others

What the payments were for

  • Food & beverage$9,50298%
  • Education$1632%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$9,665 in reported general payments places this provider in the 95th percentile of 2,084 family medicine providers in New Jersey.

See all family medicine providers in New Jersey

Medicare billing

Part B allowed, 2024
$516,252
Medicare patients
747
Services billed
8,284

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban85$81,319
OzempicSemaglutide53$73,500
JardianceEmpagliflozin72$65,120
XareltoRivaroxaban17$25,679
JanuviaSitagliptin Phosphate25$24,479
MounjaroTirzepatide11$16,710
TradjentaLinagliptin11$11,955
JanumetSitagliptin Phos/Metformin Hcl13$11,552
Rosuvastatin Calcium542$9,237
Dexlansoprazole DrDexlansoprazole15$7,719
Icosapent Ethyl27$4,948
Olmesartan-Amlodipine-HctzOlmesartan/Amlodipin/Hcthiazid30$3,993
Atorvastatin Calcium392$3,935
Levothyroxine Sodium311$3,823
Olmesartan-HydrochlorothiazideOlmesartan/Hydrochlorothiazide62$3,613

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$385$81,31985 claims
Boehringer IngelheimJardiance, Tradjenta$508$77,07583 claims
Novo NordiskOzempic$2,621$73,50053 claims
MerckJanuvia, Janumet$235$36,03138 claims
Johnson & JohnsonXarelto$262$25,67917 claims
Lilly USA, LLCMounjaro$360$16,71011 claims
AbbVieSynthroid$667$2,20949 claims
ANI Pharmaceuticals, Inc.Valsartan$19$1,18330 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,084 family medicine providers in New Jersey.

Other family medicine in Wood Ridge

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →